Access Statistics for Jo Seldeslachts

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A Retrospective Evaluation of the GDF/Suez Merger: Effects on Gas Hub Prices 0 0 0 46 1 8 14 94
A Retrospective Study of State Aid Control in the German Broadband Market 0 0 0 21 0 2 8 44
A Retrospective Study of State Aid Control in the German Broadband Market 0 0 0 23 2 7 16 56
A Retrospective Study of State Aid Control in the German Broadband Market 0 0 0 22 0 1 15 54
A retrospective evaluation of the GDF/Suez merger: Effects on gas hub prices 0 0 0 55 0 5 13 76
Acquiring R&D Projects: Who, When, and What? Evidence from Antidiabetic Drug Development 0 0 3 13 1 8 31 45
Acquiring R&D projects: who, when, and what? Evidence from antidiabetic drug development 0 0 2 2 0 0 10 14
Acquiring R&D projects: who, when, and what? Evidence from antidiabetic drug development 0 0 1 16 0 5 19 32
Are M&As Spurring or Stifling Innovation? Evidence from Antidiabetic Drug Development 0 1 28 28 0 3 58 58
Are M&As spurring or stifling innovation? Evidence from antidiabetic drug development 0 1 13 13 2 3 27 27
Collusion through Joint R&D: An Empirical Assessment 0 0 1 64 0 4 13 127
Collusion through Joint R&D: An Empirical Assessment 0 0 0 78 1 5 13 199
Collusion through joint R&D: An empirical assessment 0 0 0 167 0 4 13 230
Common Ownership Patterns in the European Banking Sector – The Impact of the Financial Crisis 0 0 0 8 0 3 8 18
Common Ownership and Market Entry: Evidence from Pharmaceutical Industry 0 0 0 61 1 6 19 273
Common Ownership and Market Entry: Evidence from the Pharmaceutical Industry 0 0 0 0 1 5 5 5
Common Ownership and Market Entry: Evidence from the Pharmaceutical Industry 0 0 0 60 1 8 24 252
Common Ownership in the US Pharmaceutical Industry: A Network Analysis 0 0 0 15 2 5 8 47
Common Ownership in the US Pharmaceutical Industry: A Network Analysis 0 0 0 22 1 3 12 76
Common Ownership: Europe vs. the US 0 0 0 6 0 4 15 24
Common ownership and market entry: Evidence from the pharmaceutical industry 0 0 0 17 1 3 15 101
Common ownership and market entry: Evidence from the pharmaceutical industry 0 0 0 98 1 7 20 130
Common ownership in the US pharmaceutical industry: A network analysis 0 0 0 13 1 3 17 47
Common ownership in the US pharmaceutical industry: A network analysis 0 0 0 15 0 1 9 29
Common ownership: Europe vs. the US 0 0 0 5 0 1 11 28
Effective European Antitrust: Does EC Merger Policy Generate Deterrence 0 0 0 44 2 5 15 82
Effective European Antitrust: Does EC Merger Policy Generate Deterrence 0 0 0 34 0 1 6 68
Effective European antitrust: Does EC merger policy generate deterrence? 0 0 0 1 1 2 6 43
How to Measure the Deterrence Effects of Merger Policy: Frequency or Composition? 0 0 0 57 0 4 11 174
How to Measure the Deterrence Effects of Merger Policy: Frequency or Composition? 0 0 0 45 0 3 16 232
Interactions Between Product and Labour Market Reforms 0 0 0 283 0 7 19 1,099
Merger Clusters during Economic Booms 0 0 0 100 0 0 4 395
Merger Failures 0 0 0 450 0 2 14 1,340
Merger failures 0 0 0 229 0 4 23 596
Mergers, Investment Decisions and Internal Organisation 0 0 0 86 0 1 8 451
Mergers, Investment Decisions and Internal Organisation 0 0 0 343 0 6 12 1,298
Mergers, Investment Decisions and Internal Organisation 0 0 1 6 1 4 12 83
Mergers, Investment Decisions and Internal Organisation 0 0 0 192 0 1 10 480
On The Stability of Research Joint Ventures: Implications for Collusion 0 0 0 68 0 0 4 227
On the Stability of Research Joint Ventures: Implications for Collusion 0 0 0 71 0 3 11 274
Ownership Diversification and Product Market Pricing Incentives 0 0 0 1 0 0 27 32
Ownership Diversification and Product Market Pricing Incentives 0 0 0 17 2 11 36 76
Ownership diversification and product market pricing Incentives 0 0 0 2 1 3 21 29
R&D Spillovers through RJV Cooperation 0 0 0 5 0 5 14 28
R&D Spillovers through RJV Cooperation 0 0 0 9 0 3 10 30
R&D Spillovers through RJV Cooperation 0 0 0 3 0 4 12 38
R&D Spillovers throught RJV Cooperation 0 0 0 18 2 9 31 78
Remedy for Now but Prohibit for Tomorrow: The Deterrence Effects of Merger Policy Tools 0 0 0 51 1 2 7 207
Remedy for Now but Prohibit for Tomorrow: The Deterrence Effects of Merger Policy Tools 0 0 0 48 0 1 18 211
Remedy for Now but Prohibit for Tomorrow: The Deterrence Effects of Merger Policy Tools 0 0 0 69 0 2 11 287
Screening and Merger Activity 0 0 0 91 0 1 12 369
The Contingent Effect of Alliance Design on Alliance Dynamics and Performance: An Experimental Study 0 0 0 30 0 3 11 62
The Deterrence Effects of U.S. Merger Policy Instruments 0 0 0 15 0 3 17 108
The Deterrence Effects of U.S. Merger Policy Instruments 0 0 0 32 1 4 9 149
The Dynamics of Research Joint Ventures: A Panel Data Analysis 0 0 0 108 0 3 13 387
The Dynamics of Research Joint Ventures: A Panel Data Analysis 0 0 0 96 0 2 9 321
The Impact of Competition Policy Enforcement on the Functioning of EU Energy Markets 0 0 2 137 0 11 29 158
US and EU Secure Vaccine Production on Home Soil 0 0 0 13 0 1 3 53
USA und EU setzen auf lokale Impfstoffproduktion - Versorgungssicherheit im Fokus 0 0 0 3 0 0 2 27
What Clients Want: Choices between Lawyers' Offerings 0 0 0 13 0 3 10 62
What Clients want: Choices between Lawyers' Offerings 0 0 0 17 2 5 9 57
What clients want: Choices between lawyers' offerings 0 0 0 2 2 4 15 43
Total Working Papers 0 2 51 3,657 31 227 910 11,740
2 registered items for which data could not be found


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A Retrospective Evaluation of the GDF/Suez Merger: Effects on the Belgian Gas Hub 0 0 0 0 1 3 8 11
A Retrospective Study of State aid Control in the German Broadband Market 0 1 1 1 1 6 6 6
Ausbau der deutschen Grundbreitbandversorgung: Lehren aus der Vergangenheit mahnen zur Besonnenheit 0 0 0 4 0 3 7 28
Changes in Common Ownership of German Companies 1 1 3 54 1 4 19 193
Collusion Through Joint R&D: An Empirical Assessment 0 0 0 54 0 5 18 214
Common Ownership Patterns in the European Banking Sector—The Impact of the Financial Crisis1 0 0 2 3 1 1 8 11
Common Ownership and Market Entry: Evidence from the Pharmaceutical Industry 0 0 3 3 1 7 25 25
Common Ownership in the U.S. Pharmaceutical Industry: A Network Analysis 0 0 0 0 1 7 13 16
Deutschland muss seine Digitalstrategie überdenken, um den Anschluss nicht zu verlieren: Editorial 0 0 0 3 0 3 8 40
Diversification, Common Ownership, and Strategic Incentives 0 0 0 18 1 4 9 61
EFFECTIVE EUROPEAN ANTITRUST: DOES EC MERGER POLICY GENERATE DETERRENCE? 0 0 0 3 0 0 10 61
EU Competition Policy Enforcement Supports Investment in the Energy Sectors 0 0 0 4 0 1 11 42
EU-Regionalbeihilfen haben positiven Einfluss auf Investitionen 0 0 0 2 0 1 5 17
EU-Wettbewerbspolitik fördert Investitionen in den Energiesektoren 0 0 0 2 0 1 4 34
Effective European Antitrust: Does EC Merger Policy Generate Deterrence? 0 0 0 4 0 1 5 31
Endogenous mergers and endogenous efficiency gains: The efficiency defence revisited 0 0 0 87 1 5 18 289
Europeanization of EU member-state competition policy: The commission's leadership role 0 0 0 14 0 5 8 83
Harte Restriktionen scheinen die wirksamste Maßnahme zu sein, um in einer Pandemie den Flugverkehr zu beschränken: Interview 0 0 0 0 0 2 3 3
How to Measure the Deterrence Effects of Merger Policy: Frequency or Composition? 0 0 0 33 0 4 14 136
Learning dynamics in research alliances: A panel data analysis 0 0 0 32 1 2 12 238
Let’s Not Stick Together: Anticipation of Cartel and Merger Control in The Netherlands 0 0 0 20 0 6 10 97
Mandanten von Anwälten wollen kein Stundenhonorar 0 0 0 1 0 0 2 37
Mehr gemeinsame Anteilseigner, mehr US-Investoren: Eigentümerstrukturen deutscher Firmen haben sich verändert 0 0 0 2 0 2 5 13
Merger Failures 0 1 3 12 0 6 26 195
Nur harte Corona-Regeln wirken sich auf den Passagierflugverkehr zwischen Deutschland und Mallorca aus 0 0 0 1 1 2 5 9
On the Stability of Research Joint Ventures: Implications for Collusion 0 0 0 0 2 3 9 51
Only Strict Coronavirus Regulations for Vacationers Affect Passenger Air Traffic between Germany and Mallorca 0 0 0 0 1 1 4 15
Paying by the Hour: The Least Appealing Option for Clients of Lawyers 0 0 0 0 1 1 4 47
R&D Spillovers through RJV Cooperation 0 0 0 0 1 3 22 24
R&D spillovers through RJV cooperation 0 0 0 4 1 3 20 44
SCREENING AND MERGER ACTIVITY 0 0 0 0 0 2 13 102
SYNCHRONISING DEREGULATION IN PRODUCT AND LABOUR MARKETS 0 0 0 7 0 1 9 53
Schepping en vernietiging van banen: De invloed van O&O-actieve bedrijven 0 0 0 0 0 1 4 32
Settle for Now but Block for Tomorrow: The Deterrence Effects of Merger Policy Tools 1 2 3 51 3 5 19 204
The Deterrence Effects of US Merger Policy Instruments 0 0 1 19 0 4 20 139
The Impact of Competition Policy Enforcement on the Functioning of EU Energy Markets 0 0 0 0 2 6 20 20
The Impact of Competition Policy Enforcement on the Functioning of EU Energy Markets 0 0 0 2 2 10 19 22
The Pricing Structure of Legal Services: Do Lawyers Offer What Clients Want? 0 0 1 2 1 5 13 27
The political economy of mobile telecommunications liberalization: Evidence from the OECD countries 0 0 0 70 0 6 20 263
Transformational Strategies and Productivity Growth: A Transformational‐Activities Perspective on Stagnation in the New‐Normal Business Landscape 0 0 0 2 2 5 11 23
US-Vermögensverwalter gewinnen in Deutschland an Bedeutung: Interview 0 0 0 0 1 2 8 11
Veränderungen bei gemeinsamen Eigentümerstrukturen deutscher Unternehmen 0 0 0 3 0 1 3 20
Wichtig ist es, die Innovationseffekte der vielen Übernahmen zu berücksichtigen: Interview 0 0 0 0 0 1 3 4
Übernahmen in der Pharmaindustrie: Fokus mehr auf Innovationsmärkte als auf Marktverdrängung richten 0 0 0 1 0 2 4 10
Total Journal Articles 2 5 17 518 27 143 484 3,001
3 registered items for which data could not be found


Statistics updated 2026-06-04